TLDR
- Ulta Beauty shares tumbled over 10% following Q4 results, pressured by weaker-than-expected full-year guidance and a bottom-line shortfall
- Q4 delivered EPS of $8.01, surpassing both company projections and analyst consensus; sales reached $3.90B, representing an 11.8% annual increase
- Comparable store sales climbed 5.8% in Q4, with positive momentum spanning all primary product categories
- Management’s FY2026 comp sales forecast of 2.5%–3.5% fell short of Street expectations, while operating margin is projected to remain essentially unchanged
- The company announced a $1 billion share repurchase program for the current year; institutional holders control 90.39% of shares, with analyst consensus at “Moderate Buy” and $671.27 average target
Ulta Beauty delivered what appeared to be a respectable fourth quarter on paper, yet investors zeroed in on what the report lacked: stronger earnings numbers and more aggressive forward guidance. Shares plummeted more than 10% following the announcement, extending losses to approximately 19% since Barron’s highlighted the stock as an attractive pick just weeks earlier.
The beauty retailer reported Q4 earnings per share of $8.01, topping the Street’s $7.93 consensus by $0.08. Sales totaled $3.90 billion, representing an 11.8% increase from the prior year and exceeding analyst projections of $3.81 billion. Gross profit margins also came in ahead of expectations. What triggered the selloff? Certain more aggressive profit estimates weren’t met, and the fiscal 2026 outlook proved too conservative for investors’ liking.
For the current fiscal year, executives projected comparable sales expansion of 2.5% to 3.5% — landing below the Street’s midpoint forecast — while indicating operating margins would remain approximately flat. Rising marketing expenditures, elevated incentive pay, and expanded strategic initiatives are pressuring margins. Additionally, the company faces more challenging year-over-year comparisons after FY25’s strong performance.
A recently appointed CFO may partially account for the measured guidance approach. Raymond James analyst Olivia Tong observed that this conservative stance aligns with Ulta’s traditional forecasting methodology and is likely amplified by current geopolitical uncertainties.
Analysts Trim Targets, Mostly Hold Ratings
While the market responded aggressively, few analysts downgraded their ratings. UBS maintained its “buy” recommendation and preserved its $810 price objective. William Blair analyst William Carden suggested the sharp decline “could close quickly” following the recalibration of 2026 expectations around flat margin assumptions. TD Cowen’s Oliver Chen emphasized Ulta’s “low-to-luxe” product range as an enduring competitive advantage.
The overall analyst consensus remains at “Moderate Buy,” comprising 15 Buy ratings, 10 Holds, one Strong Buy, and a single Sell. The mean price target stands at $671.27, compared to Monday’s opening price of $535.72 — suggesting substantial upside potential if operational performance meets expectations.
Zacks adjusted its rating from “Strong Buy” to “Hold” in February, prior to the earnings release. Jefferies, which launched coverage in January, carries a “Hold” rating with a $700 target.
Institutional Buyers Adding Exposure
Despite the selloff, some institutional players moved in the opposite direction. Holocene Advisors LP expanded its ULTA holdings by 339.6% during Q3, acquiring an additional 293,516 shares for a total position valued at approximately $207.7 million. Focus Partners Wealth, Intech Investment Management, and various other funds similarly increased their stakes in recent quarters.
Institutional ownership now represents 90.39% of outstanding shares.
The 5.8% Q4 comparable sales growth stands in stark contrast to flat comps at Kohl’s Sephora operations. Digital channels are gaining traction, with AI-powered personalization identified as a key growth catalyst. The retailer also plans to introduce a curated TikTok Shop targeting younger demographics.
Shares have traded in a 52-week range between $323.36 and $714.97. Monday’s opening price of $535.72 sits considerably below both the 50-day moving average of $665.60 and the 200-day moving average of $587.65.
Management established FY2026 EPS guidance at $28.05–$28.55, compared to the current analyst consensus of $23.96 for the fiscal year.





